Back to 
Point72 Asset Management, L.P.
Point72 Asset Management, L.P.
FDMT
Showing 4 of 11 quarters
Position history for Point72 Asset Management, L.P.'s holdings in 4D Molecular Therapeutics, Inc.
No. Point72 Asset Management exited its FDMT (4D Molecular Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 1,539,860 shares worth $11.5M. Point72 Asset Management first reported FDMT in Q3 2022 and held it in 8 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$165,840
Total Shares Change
-15,341
Quarter-by-Quarter History